Mycoplasma pneumoniae is a slow-growing, human pathogen that causes atypical pneumonia. Because it lacks a cell 39 wall, many antibiotics are ineffective, and vaccination is required. Due to its reduced genome and dearth of many 40 biosynthetic pathways, this fastidious bacterium depends on rich, undefined medium for growth, which makes large-41 scale cultivation for vaccine production challenging and expensive. 42
Introduction

52
Mycoplasma are a small genus of bacteria belonging to the Mollicute class, 1 comprising 124 species, 14 of which are 53 human pathogens, 2 while others infect farm animals, herd animals and pets. 3 Most large-scale animal farms make use 54 of antibiotics to fight and prevent infections, which often lead to development of antibiotics-resistant bacteria. 4-6 55
Moreover, chronic infections caused by several Mycoplasmas are not immediately detectable. The use of effective 56 vaccines against various Mycoplasmas in farm animals is essential to prevent wide spreading of these chronic 57 infections 7 . It has been suggested that, despite being primarily considered a human pathogen, Mycoplasma 58 pneumoniae (MPN) could potentially be used as a universal chassis to be deployed as single-or multi-vaccine in a 59 range of animal hosts (www.mycosynvac.eu). 60 MPN causes atypical or walking pneumonia. 8 With its highly reduced genome (816 kb), it is among the smallest self-61
replicating living organisms and has an exclusively parasitic lifecycle. This feature greatly determined its evolution 62 towards minimal functions (e.g. absence of vitamins and lipids synthesis) and inability to detoxify metabolic waste 63 (e.g. hydrogen peroxide), tasks for which this bacterium fully relies on the host. 9 MPN primarily ferments glucose 10 64 and uses most of its energy (71 to 88%) for non-growth associated tasks 11 . One of the key features of MPN during 65 infections is its ability to evade the immune system: the unique characteristics of its membrane (in particular the high 66 cholesterol contents) allows the mimicking of the host membrane. 12 Moreover, the lack of a cell wall makes it resistant 67 to antibiotics which target this structure. 13 68
The development of vaccines based on MPN requires the large-scale production of this bacterium in minimal 69 chemically defined medium. This is due to the high economic cost of rich media, the variable composition of animal-70 derived compounds 14 and the possible presence of toxins, viruses or antigens that could reduce the sensitivity of 71 immunological assays used on farms to screen for infection. 15 However, the production of MPN in defined media is a 72 major challenge. For decades, the ability to culture MPN was reported to be possible only in serum-rich media 16 due 73 to a requirement for sterol components. 17 Only in 2009 Yus et al. reported a defined medium based on the metabolic 74 map reconstruction of MPN that allowed some growth of the bacterium but required daily changes of the medium 18, 19 . 75
This medium is not valid for large-scale growth needed during vaccine production. For these reasons, we focused our 76 study on the model-driven design of a serum-free medium that could improve MPN growth rate. 77
We approached the study through metabolic modeling, a method widely used for genome-scale biochemical networks 78 analysis. [20] [21] [22] [23] [24] [25] [26] [27] . We previously described the development of a genome-scale, constraint-based model (GEM) of MPN 79 metabolism, iJW145, 28 and its use to carry out predictions related to growth rate and medium design, relying upon a 80 biomass composition that had been formulated from literature, 3 sequencing, proteomics and mass spectrometry data. 81 Razin et al. 3 reported the biomass of MPN is composed of 54-62% protein, 12-20% lipids, 3-8% carbohydrates, 8-17% 82
RNA and 4-7% DNA. However, no novelty in the defined medium composition was reported 28 . Several studies show 83 that lipids were the most important component limiting growth, mainly cholesterol, regulating membrane fluidity, and 84 fatty acids. 1, [29] [30] [31] [32] Determining the lipids composing the membrane of MPN is challenging, as it is strongly dependent 85 on the composition of the growth medium, growth phase and culture conditions. 33 Some key features remain 86 invariant, such as the high cholesterol proportion, directly incorporated from the medium. 34 The model iJW145 did 87 not account in detail for lipids in its biomass composition 11, 28 . Therefore, we integrated native lipid pathways of MPN, 88 and reactions involved in the membrane formation to develop an updated GEM of MPN metabolism, called 89
iEG158_mpn. 90
We aimed to describe the use of the energy available, taking into account not only cytosolic processes but also 91 transmembrane transport. We used the model iEG158_mpn to design serum-free media for MPN and studied in detail 92
how culture conditions affect the growth of MPN, focusing on chemical-physical aspects of the intracellular 93 metabolism. Our study, in combination with the existing literature, suggests membrane formation and adaptability 94
are key aspects to be investigated in relation with MPN growth, which appears to be limited by several factors. 95 96
Materials and Methods
97
Reconstruction of the genome-scale, constraint-based metabolic model 98
The metabolic model iJW145 28 was extensively updated, manually curated and expanded to generate the genome-99 scale metabolic model iEG158_mpn. Reactions and metabolites have been annotated adding BiGG Models identifiers 35 100 when possible. Reaction reversibility has been assessed through eQuilibrator, 36 a thermodynamic calculator of the 101
Gibbs energy released by a specific reaction at a set pH and ionic strength (in our case, respectively 7.0 and 0.1M). 102
Reactions where changes in Gibbs energy comprised between -30 and 30 kJ/mol were considered reversible, otherwise 103 irreversible. All model reactions have been manually verified using information from the MyMpn database. 37 104
Information gathered from literature was used to modify the biomass synthesis reaction adding detailed information 105 on lipid composition. Reactions for fatty acid integration into membrane lipid chains have been added. The genome-106 scale model iEG158_mpn is in SBML format and its syntax and consistency has been checked with SBML Validator. 38 
107
A list of all reactions and metabolites IDs is given in Supplementary Table S1 . The model has been deposited in 108
BioModels 39-41 and assigned identifier MODEL1912060001. A python script to simulate growth with this model, 109
imposing constraints and supplementing in silico the medium, is provided as Supplementary File S1. 110
Model simulations and medium design 111
Pathways and whole-metabolism maps for fluxes visualization were constructed with the tool Escher, 42 which 112 graphically depicts a solution for maximum attainable growth rate, as computed by Flux Balance Analysis (FBA), with 113 biomass yield, as a proxy for growth, as the objective function. 43 FBA solves a linear programming problem, which is 114 characterized by having more variables than equations, meaning more than one optimal solution can exist for the 115 same objective function maximization. FBA computes a possible flux distribution leading to the optimal objective 116 solution. The same optimal growth rate might be reached by several different reaction flux combinations. Flux 117
Variability Analysis (FVA) explores the range of each metabolic flux at the optimal solution. 44 Both FBA and FVA were 118 run with biomass synthesis reaction as objective function to maximize, respectively, through the commands optimize() 119
and flux_variability_analysis() of the Python tool cobrapy, 45 version 0.5.11 (Python version 3.4.4). Exchange reactions 120 in a genome-scale metabolic model allow metabolites to enter and egress the in silico network. Simulations with 121 iEG158_mpn were performed by conserving the same flux constraints as have been experimentally determined: these 122 assumed unlimited availability of the compounds which are not directly metabolized for energy or carbon and/or 123 cannot be measured experimentally (vitamins, cofactors). Additional fatty acids that could be metabolized or 124 integrated as membrane lipid chains (palmitic acid, palmitelaidic acid, stearic acid, oleic acid, linoleic and linolelaidic 125 acid) have also been assumed to have unlimited availability as no related uptake rates were experimentally measured. 126
Specifically, exchange reactions corresponding to metabolites whose uptake or secretion rate was not measured were 127 set with bounds of ± 1000 when production and secretion was possible, with a lower bound of -1000 and an upper 128 bound of 0 when only uptake from medium was possible and with a lower bound of 0 and an upper bound of 1000 129 when describing secretion. 130
Growth medium optimization consists of changing the bounds of exchange reactions to enable or limit uptake or 131 secretion in order to find the combination of supplemented compounds that maximizes the flux through the biomass 132 reaction, if this corresponds to maximizing growth rate. We tested the possible uptake of additional native compounds 133 not previously considered in MPN growth media, but for which transporters are present in MPN genome, by adding 134 the corresponding exchange reactions ( Supplementary Table S1 ). To equilibrate the energetics in the model, we 135 assigned a cost of 1 proton for the uptake of uncharged compounds, 1 ATP for the uptake of compounds with a charge 136 of 1 or 2 and 2 ATPs for the one of compounds with charge greater than 2. To design a minimal chemically defined 137 medium that optimizes MPN growth, we iterated through all the exchange reactions present to find the combination 138 of bounds that lead to the highest biomass production: we have initially set all the exchange reactions' lower bounds 139
to -1000, allowing the metabolites of interest into the system. All the lower bounds of the exchange reactions were 140 set to 0 one at a time, to be then repristinated to -1000 for the next iteration (next exchange reaction to close). When 141 biomass yield was not changing in consequence, we assumed the component was not required for maximizing growth 142 rate. Each time a component was removed from the list, a new set of iterations was started on all the other 143 components. The minimal medium was obtained once all the components, when removed (i.e. when the 144 correspondent exchange reaction's lower bound was set to 0), were changing the biomass yield obtained by FBA. The 145 relation between the growth rate and the doubling time has been computed using the exponential function e µT =2, 146
where µ is the growth rate in divisions per unit of time and T is the doubling time. 147
To simulate hypoxia, we first ascertained, through Flux Balance Analysis, the minimal oxygen uptake rate required for 148 optimal growth by iEG158_mpn. By allowing in silico an infinite supplementation of oxygen ("EX_O2_e" reaction lower 149 bound = -1000), we ran FBA towards flux maximization of the biomass reaction. Constraining the growth rate to the 150 maximal one, following FBA with as objective function "EX_O2_e" (minimization of oxygen uptake), we computed the 151 minimal oxygen required. Once this value is established as the minimal oxygen uptake required for optimal growth, 152
we reduced the oxygen supplementation (i.e. subsequent increments of "EX_O2_e" reaction lower bound from 153 maximum oxygen uptake rate in baseline conditions towards 0) until reaching a biomass flux of 0, meaning no growth 154 in silico. Following this approach, we extracted the minimum required oxygen to be supplemented in silico to allow 155 growth. We then performed simulations of iEG158_mpn with an intermediate oxygen supplementation resulting from 156 the rounded calculation of the mean of the minimal oxygen uptake required for optimal growth and the minimal 157 oxygen required for allowing growth. 158
In silico prediction of optimal medium lipids based on membrane composition 159
Optimal lipid composition of the medium was predicted according to the scheme in Figure 1 . Each candidate medium 160 lipid was integrated into the cytosol and subsequently into membrane compartment of biomass in three possible 161 alternative ways: through direct integration, after being metabolized or after synthesis from precursors in the medium. 162
Each lipid is considered carrying quantities of fatty acids, allowing the optimization not just of the membrane lipids 163 but also of an experimentally determined fatty acids profile. Not only one but several proportions distributions of the 164 membrane composition are considered, according to the ones detected in literature (as in our model: see 165 Supplementary Table S2 ). Optimization of the lipids in the growth medium (see previous section) is then performed 166 balancing both optimal fatty acid profile and variable membrane compositions, in order to predict a consensus 167 medium composition able to allow growth under all the membrane configurations detected during laboratory 168 cultivation. 169 170 171 172 Figure 1 . In silico optimization strategy for predicting optimal lipid composition of growth medium. All the possible 173 lipids and precursors are provided in the medium for uptake. Each possible membrane composition that is found in the 174 literature can be incorporated in the model as part of the biomass synthesis reaction. In our case, we considered three 175 membrane compositions whose lipid proportions change according to the cholesterol percentage. Fatty acid profile can 176
be found in literature (as in our model) or be experimentally determined. Lipid1 is known to be directly incorporated 177
into the membrane, Lipid2 is metabolized in the cytosol and, whether a lipase acts, degraded into component head group 178
and fatty acids. Lipid3 is synthetized in the cytosol from lipid precursors. Each lipid is integrated into the membrane 179
according to the compositions previously reported in the literature. According to the optimal membrane composition 180 and fatty acid profile, a consensus minimal lipid composition of the medium is predicted. 181
Sequence alignment 182
By querying manually-curated sequences in the UNIPROT database, 46 we verified the presence of lactate and acetic 183 acid transporters and general monocarboxylic acid transporters in the MPN genome (Supplementary Files S2). PSI-184
BLAST algorithm 47 was run with default parameters until convergence was reached to build a sequence profile of the 185 transporters (Position Specific Scoring Matrix provided in Supplementary Files S2), then used to query within MPN 186 genome for presence of these transporters. In addition, we searched for monocarboxylic transporters in MPN by 187 running a BLASTp search with default parameters on all its transmembrane proteins, whose list was available on the 188
MyMpn portal (August 2018), 37 filtering for proteins containing transmembrane helices. 189
Cultivation conditions for experimental validations of lipid requirements 190
M. pneumoniae strain M129 was grown in 75cm 2 Tissue Culture Treated Flasks (Falcon) in a serum-free medium 191 previously used for growing Mesoplasma florum. 48,49 Palmitic acid, oleic acid and cholesterol were added to this 192 medium at a final concentration of 16.5 µg mL -1 , 20 µg mL -1 and 20 µg mL -1 , respectively. Cells were grown and 193 passaged three times in absence or presence of sphingomyelin and phosphatidylcholine at 20 µg ml -1 before 194 performing any analysis. Each passage was performed by diluting the cells 50 times in fresh serum-free medium after 195 two weeks of culture. Medium was replaced by fresh serum-free medium every 7 days. 196
Passage 3 cells DNA were measured by qPCR using oligonucleotides MPN628/5 (GCCATTTTGGATGGTTATGG) and 197 MPN628/3 (GGTGACCCACTTCCGAGTTA) and the Luna® Universal qPCR Master Mix (New England Biolabs). The DNA 198 quantification was performed using the LightCycler® 480 software (Roche). Cells were diluted in 15 mL to an equivalent 199 of 0.6 pg mL -1 of DNA and distributed in aliquots of 0.2 mL in 96-well Tissue Culture Treated flat plates (Nunc). Every 200 12h, the medium from 6 wells were recovered in 1.5 mL tubes and centrifuged 15 min at 12 000g. 0.2 mL of nuclease-201 free water were added to the empty wells to lyse adherent cells by osmotic shock and then recovered and added to 202 the previous pellet to lyse non-adherent cells. Finally, they were incubated 10 min at 98°C and stored at -20°C. After 203 120h, the DNA of each sample was measured by qPCR as previously described and the growth curve was then plotted 204 and analysed using the R software (version 3.4.4). 205
M. pneumoniae strain M129 was grown in a 96-well plate format at 37°C in a serum-free medium developed by CRG. 206 Growth curves comparing the performance of the serum-free medium containing phosphatidylcholine (PC), 207 sphingomyelin (SMP) or both were recorded in a Tecan Spark plate reader by determining the growth index value, 208
which is the ratio of absorbance at 430 nm and 560 nm of the culture medium. 19 Total cell biomass obtained at the 209 end of the growth curve (96h) was also determined by protein quantification using the Pierce BCA protein assay kit as 210 previously described. 19 Disclosure of the serum-free medium composition is prevented by third party agreements, but 211 it may be available upon personal request, exclusively for validation purposes, under a material transfer agreement 212 with CRG. iEG158_mpn as the decomposition of a general protein compound into the essential amino acids and the associated 229 ATP cost. 230
The very small size of MPN contributes to the increase in maintenance costs, as the high surface-to-volume ratio 231 induces higher proton leakage through the membrane. The ATP maintenance reaction was determined in iJW145 by 232 multiplying the number of ATPase complexes on the cell surface by the number of cells in a gram of biomass, so 233 considering only the cytosolic side of the energy requirement. However, the reaction fluxes representation allowed 234 the visualization of a flux of protons out of the cell, required for the cytosol de-acidification. Moreover, it is stated in 235
Wodke et al. 28 that the proportion of ATP used in cyclical lysis (which corresponds to total non-growth associated 236 maintenance energy in iJW145) is about 76% at 24h after inoculation. We updated the non-growth-associated 237 maintenance reaction to include both a cyclical ATP lysis component (33% of the total non-growth associated ATP 238 consumption)(model reaction ID: "IR08984") and a proton leakage component (66% of the total non-growth 239 associated ATP consumption)(model reaction ID: "protonLeak"), as represented in Figure 2 . Furthermore, this 240 introduced a link between the maintenance equation and the proton production/consumption reactions. iEG158_mpn. In iEG158_mpn simulations, ATP synthase is observed to run in reverse to allow efflux of protons 246
for cytosol de-acidification. Maintenance reaction in iEG158_mpn was therefore updated to include a cyclical ATP 247 lysis component (33%) and a proton leakage component (66%). The updated maintenance reaction in iEG158_mpn 248
is compared to the one of iJW145, where only cyclical ATP lysis is assumed to be determinant. 249 250
The maintenance reaction in iEG158_mpn was further updated according to the results of the sequence alignment for 251 monocarboxylic acids transporters discovery: no lactate or acetate proton symporter were identified to be present in 252 MPN genome. The respective transport reactions (IDs "LACLt" and "IR09888") were therefore updated in iEG158_mpn 253
as irreversible, removing the proton symport and the maintenance costs adjusted to the maximum value allowing 254 growth, computed as 10.46 mmol.gDW -1 .h -1 of ATP (gDW=grams dry weight) used for non-growth-associated tasks at the 255 quasi-steady state (24h time point).
256
ATP lysis and proton leakage are modelled in iEG158_mpn according to the described proportions of the maintenance 257 energy usage: assuming the total maintenance cost, Mt, equals to 10.46 mmol.gDW -1 .h -1 of ATP, the energy fraction 258 spent for proton leakage, EP, equals to 0.66 and the one used in ATP lysis, EL, equals to 0.33, the lower bounds PLB and 259
LLB of the correspondent reactions (proton leakage and ATP lysis) are computed as [1] and [2]: 260 = . . 4
[1] = .
[2] 261 PLB is multiplied by 4 as the reverse ATP synthase reaction removes four protons at a time. 262
We simulated the growth rate of MPN with iEG158_mpn supplementing in silico the medium predicted with model 263 iJW145: the resulting growth rate is 0.053 divisions per hour at quasi-steady state of MPN (24h), correspondent to a 264 doubling time of 13.4 hours, in line with the experimental evidences. 265
Reconstruction of an optimal membrane lipids composition in iEG158_mpn 266
A model including only metabolic information has been shown not to be substantial to predict efficient strategies to 267 maximize growth. 28 Because membrane adaptability is one of the key features of MPN, we assumed that accounting 268
for membrane formation in the model would give important insights into MPN growth. Focusing on membrane lipid 269 components, we included in iEG158_mpn the pathways for lipids assembly 51 and reconstructed the membrane lipid 270 composition through an extensive literature search. Articles listed in this section were used to determine lipids 271 percentages in the membrane and their acyl chains composition. Only lipids whose percentage in the membrane has 272 been reported to be higher than 1% of the total lipid biomass were considered. Presence and proportions of the lipids 273 are strongly dependent on the compound's availability in the medium, therefore quantities must be interpreted as 274 ranges. 275
One of the key features of the MPN's membrane is the high proportion of cholesterol, from 35% to 50% of the total 276 lipid fraction. 52 In vitro, cholesterol is directly incorporated from the medium without being processed by the 277 bacterium. For this reason, in iEG158_mpn, cholesterol has been included into the biomass composition without being 278 metabolically processed. However, its proportion with respect to the other components in an optimal medium is easy 279 to predict thanks to available literature, which indicates it constitutes about one third of the final membrane and about 280 half of the lipid components of the membrane. 281
Most of the studies on MPN utilize Hayflick media, composed for 16% of horse serum, rich in sphingolipids and 282 phosphatidylcholine. 53 Sphingolipids-phosphatidylcholine ratio in MPN is 2.4, 54 constituting on average 12% and 5% of 283 the membrane lipids, respectively. 55 However, sphingolipids have a good affinity for cholesterol, while 284 phosphatidylcholine repels it, meaning their proportions in the MPN membrane are strongly correlated to the amount 285 of cholesterol directly incorporated from the medium: a higher amount of cholesterol leads to the incorporation of a 286 higher fraction of sphingolipids and a lower fraction of phosphatidylcholine 56 . The interrelation between these two 287 lipids suggests their essentiality in the membrane is strongly related to their fatty acid chains, being the only lipids 288 carrying the unsaturated fatty acid chain C18:2, whose presence might be determinant in MPN membrane. Moreover, 289
sphingomyelin incorporated into the membrane has a lower proportion of fatty acid chains with 20 carbons or more 290 in respect to the sphingolipids in the serum 57 , suggesting MPN preferentially incorporates in the membrane 291 sphingomyelin with less than 20 carbons-fatty acid chains. MPN is a fatty acid and sterol auxotroph, but it can 292 assemble phosphatidic acid, diacylglycerol, phosphatidylglycerol and glycolipids from provided fatty acids in the 293 medium. 51 Glycolipids constitute a range of 5-15% of the total membrane lipids, 58 while the remaining percentage 294
should be constituted by phosphatidylglycerol; phosphatidic acid and diacylglycerol, being lipid synthesis 295
intermediaries, are not found in relevant proportions in the membrane. 296
The lipids, with their specific molecular weight, were included in the biomass equation to reflect the predicted 297 membrane composition. We assumed a lipid composition is optimal when it confers optimal fluidity, and so 298 permeability, to the membrane of MPN. Therefore, the acyl chains of the lipids constitute a critical aspect of our 299 optimization. 300
With the aim of linking the membrane lipid profile to the availability of fatty acids in the medium, we reconstructed 301 the acyl chains of the various lipids composing the membrane by considering that the sum of fatty acid chain fractions 302 were previously determined by Wodke et al. 28 and Worliczek et al. 57 ; a comparison of the total fatty acid composition 303 between our model and the ones available in literature is provided in Supplementary Figure S1 . MPN tends to 304 selectively incorporate palmitic acid over stearic acid in the membrane 32 , with a preference for saturated fatty acids, 305
suggesting oleic and linoleic acids are incorporated in a lower proportion with respect to the amount found in the 306 media. This indicates that the proportion of different acyl chains for de-novo assembled phosphatidic acids is 307 conserved during assembly of downstream lipids phosphatidylglycerol, diacylglycerol and glycolipids. We assumed 308 phosphatidylcholine could be degraded in silico into glycerol-3-phosphocholine and fatty acids, to represent the re-309
arrangements of the phospholipid's acyl chains, which could be triggered by membrane lipases in vivo [REF] . 310
Sphingomyelin, on the other hand, is in our model directly incorporated into the membrane without modifications: 311
we therefore kept for this lipid the same fatty acid composition in the membrane as supplemented in the medium. 312
A representative average membrane lipids composition of MPN grown on serum rich medium is shown in Figure 3 , 313 with its respective and total fatty acid chains. In order to predict in silico the composition of serum-free medium that 314 would maximize the growth of MPN, we added to the biomass equation the above representative medium 315 composition, excluding those whose supplementation is linked to the addition of serum or would deviate from the 316 optimal fatty acids proportions (e.g. cardiolipin). This way, simulating iEG158_mpn with as objective the maximization 317 of the biomass flux (i.e. growth rate), we optimized for both growth and optimal membrane formation. We excluded 318 phosphatidic acid from the biomass equation in iEG158_mpn and consider it solely as precursor of 319 phosphatidylglycerol and glycolipids. Figure 4 consists of a visual representation of lipid pathways and membrane 320 construction as they have been implemented in iEG158_mpn. The membrane is then composed of cholesterol, 321 phosphatidylcholine, phosphatidylglycerol, glycolipids and sphingomyelin. We reconstructed their pathways within 322 MPN metabolism and linked them to the medium components supplementing the related lipids. We included in the 323 biomass equation the reported lipids, with their acyl chains, in their optimal proportion and maximize its flux to get 324 the medium composition which enables growth. 338  339  340  341  342  343  344  345  346  347  348   349   350  351  352  353  354  B)  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387 388 Figure 4 . Implementation scheme of the lipid pathways and membrane formation in iEG158_mpn, when MPN is 389 grown on serum-free medium. The wide variety of lipid species was simplified by considering all carry a 390
representative acyl chain distribution instead of a mix with different acyl chain configurations. This simplification 391
considerably reduces the complexity of the model keeping the same amount of quantitative information. A) 392
Cholesterol is directly incorporated in the membrane as well as sphingomyelin (SM), for which all the different fatty 393 acid chains proportions have been considered. Phosphatidylcholine is imported using ATP and either goes to build 394 the membrane or it is degraded into its fatty acid chains and glycerol-phosphocholine (G3PC). All the fatty acids 395
introduced in the medium (C16:0, C16:1, C18:0, C18:1, C18:2) will be linked to an acyl-carrier protein (ACP) at 396
the expense of ATP. The ACP then releases the fatty acid chain to glycerol 3-phosphate (glyc3p) and the product, 397
reacting with the ACP carrying fatty acids, leads to the production of phosphatidic acid (PA). B) PA then undergoes 398 synthesis of phosphatidylglycerol (PG) or glycolipids. 399 400 401
The possible ranges of lipids and fatty acids proportions assuming growth in serum-free media are reported in 402 Supplementary Table S2 . 403 404
Formulation of growth media incorporating specific lipids using a model-driven approach greatly increases MPN 405 growth rate in vitro 406
We integrated into iEG158_mpn reactions involved in fatty acids, lipids and membrane formation pathways to 407 reconstruct the membrane of MPN and predict essential fatty acids and lipids that, if added to the medium, could 408 allow growth. As a result of this integration, the lipids in the biomass reaction of iEG158_mpn have been distributed 409 as reported in Table 1 . 410 From this membrane reconstruction, we have knowledge of the essential components that cannot be synthetize de-414 novo and therefore must be taken up from the medium. FBA shows the optimal components of the serum-free 415 medium which maximize the growth of MPN, as shown in Table 2 . 416 
418
The result about the components directly impacting the metabolism is consistent with the one previously listed in a 419 serum-free defined medium that allowed weak growth 19 and adds lipids components (sphingomyelin and 420 phosphatidylcholine), essential for the membrane formation and stabilization. This led to the design of two 421 experiments for in vitro assessment; results shown in Figure 5 and Figure 6 prove the determinant contribution of the 422 synergy between sphingomyelin and phosphatidylcholine for MPN growth in vitro. determined by previous studies 18 . Our analysis pin-points, in terms of percentages of total lipid mass in the membrane, 441 the three key lipid components (cholesterol, sphingomyelin and phosphatidylcholine) that were integrated in 442 iEG158_mpn as follows: the most enriched components must be cholesterol, constituting 35-50% of the total lipids; 443 sphingomyelin and phosphatidylcholine proportions are adjusted accordingly, as sphingomyelin has high affinity for 444 cholesterol, while phosphatidylcholine has a low one. 56 Therefore, they constitute respectively 9-15% and 6-10% of 445 the total lipids. Figure 7 shows the interrelation between cholesterol, phosphatidylcholine and sphingomyelin (or in 446 general sphingolipids) proportions in MPN membrane as simulated by iEG158_mpn. Sphingomyelin is preferably 447 incorporated carrying an 18-carbon acyl chain and, therefore, its essentiality might be linked to it being the only one 448 carrying the acyl chain C18:2. 449 450 451 Figure 7 . Interrelation between cholesterol, sphingomyelin and phosphatidylcholine proportions in the membrane 452 of MPN as simulated by iEG158_mpn when grown in silico on the predicted optimal serum-free medium. A) If 453 cholesterol constitutes 35% of the total membrane lipids, phosphatidylcholine (PC) proportion is up to 10%, while 454 sphingomyelin/sphingolipids is reduced at its minimum to 12%. B) If cholesterol constitutes 50% of the membrane 455 lipids, phosphatidylcholine (PC) proportion decreases to 6%, while sphingomyelin increases to 15%. Outer cycle 456
represents the average proportions of acyl chains carried by each lipid, as also showed in Figure 3 : the grey colors 457
represent, in order of shading from the lightest to the darkest, C16:0, C16:1, C18:0, C18:1, C18:2. 458 459
The essential fatty acids to be incorporated in a serum-free medium are palmitic (C16:0) and oleic (C18:1) acids, as 460 they are the preferred components of phosphatidic acid in MPN and its downstream products phosphatidylglycerol 461 and glycolipids. Stearic acid (C18:0) presence is important depending on phosphatidylcholine proportion: once 462 phosphatidylcholine is incorporated, its unsaturated fatty acid chains are replaced with saturated ones, resulting in 463 the membrane di-saturated phosphatidylcholine. 59 Moreover, supplementation of phosphatidylcholine might be 464 important not only as membrane component but also as source of those fatty acids whose presence has been detected 465 in lower percentage with respect to palmitic and oleic acids: linoleic acid (C18:2) and palmitoleic acid (C16:1). 466 467
Effect of hypoxia on MPN metabolism 468
iEG158_mpn uses BiGG Models identifiers, so Escher can be applied to visualize change of fluxes when simulating 469 different environmental conditions: Figure 8 shows flux changes for each reaction in part of the glycolysis pathway of 470 the metabolic network when oxygen availability is reduced from minimal required uptake rate for maximal growth 471 (7.54 mmol.gDW -1 .h -1 ) to 6 mmol.gDW -1 .h -1 , as no growth occurs in complete absence of oxygen. 60 Our model predicts 472
absence of growth for oxygen uptake rates lower than 4.81 mmol.gDW -1 .h -1 . With no oxygen limitation and glucose 473 uptake rate of 5.11 mmol.gDW -1 .h -1 , the model predicts MPN uptakes 7.54 mmol.gDW -1 .h -1 of oxygen. The growth rate 474 under hypoxic stress, in respect to baseline conditions, is limited by about 2.3-fold. FVA results for all the reaction 475 fluxes in baseline and hypoxia conditions are reported in Supplementary Table S3 , where the reactions included in 476 Figure 8 are highlighted. Here the fluxes are represented in terms of differences between hypoxia and baseline 477 conditions, given that the solutions for the flux distributions are unique. Despite the overall fluxes' distribution being 478
slightly reduced under oxygen limitation, the number of zero-flux reactions in this condition is 84. Excluding these, 299 479
reactions have same minimum and maximum allowed fluxes. The hyper-reduced size of the FVA solution space on 480 both baseline and hypoxia, and so their unique solutions of the related FBA matrix, allow the representation of flux 481 differences between the two conditions. 482
Combining the information from FVA and the fluxes visualization, some conclusions on MPN under hypoxia can be 483 drawn. Not considering the zero-flux reactions, only 18 ( Supplementary Table S3 ) show the same range of fluxes 484 comparing the two situations (baseline and reduced oxygen) in iEG158_mpn, assuming proton leakage and 485 maintenance energy (ID: "IR08984") do not change. All the lipid synthesis reactions show a consistent flux reduction, 486
as well as the reactions related to the carbon degradation pathways and the NAD kinase. Imports of some amino acids 487
and nucleobases (i.e. thymine, ID: "IR09855") show a flux decrease when oxygen is reduced. Contrarily to the general 488 tendency, deoxyuridine kinase and phosphorylase show a higher flux respect to the baseline situation. CO2, H2O2, acetic 489 acid and lactic acid productions increase under hypoxia. Owing to its fastidious requirements, Mycoplasma pneumoniae has been thus far reported to grow on media 503 containing serum 61,62 and only poorly in defined medium 18 , furthermore requiring daily changes. Hereby, by using in 504 silico modeling approaches based on literature data, we propose two media formulations that allow MPN to grow at 505 a non-negligible rate, and we suggest that the poor growth reported in the previously defined medium was especially 506
due to the absence of sphingomyelin and phosphatidylcholine. This prediction was validated by removing these 507 phospholipids from the two different serum-free media formulations. The absence of animal-derived elements in 508 these media facilitates the large-scale production of this microorganism for medical and pharmaceutical purposes, 509 thanks to the reduced costs, greater reproducibility, definite composition and lack of unexpected serum-plate-510 agglutination (SPA) antigens 15,63 and other unpredictable contaminants. Our study shows that supplementation of 511 sphingomyelin and phosphatidylcholine to two serum-free media, together with cholesterol, enables growth of MPN. 512 We also show that the different incorporation of these lipids depends on their availability in the medium. The MPN 513 membrane is built on available resources and it is strongly variable according to the environmental conditions. The 514 lipid composition of the membrane affects its permeability 64 and curvature 65 . For instance, a sphingomyelin-515 cholesterol packing results in a very tight membrane 66 . Therefore, the key medium lipids herein found lead to the 516 hypothesis that one of the main limitations of MPN growth resides in its membrane composition, fluidity and 517 permeability. This is, in turn, determined by the proportion of acyl chains in the membrane lipids. While the 518 requirement of cholesterol for growth has been well known for decades, 30,67 phosphatidylcholine supplementation in 519 a medium for MPN has been first reported in 2009 19 . Sphingomyelin, in contrast and to the best our knowledge has 520 not been specifically reported as to be an essential component in media deployed to grow Mycoplasma pneumoniae. 521
Having established that lipids supplementation is a key aspect for MPN growth, the way they are supplemented might 522 be critical: MPN cultures where lipids are supplemented as cholesterol-phosphatidylcholine vesicles show a similar 523 growth rate of the ones in serum-rich media. 68 524 Medium composition is not the only growth-limiting factor of MPN growth in vitro: batch cultures may result in 525 limitation in oxygen supply as a result of gradients that arise due to biofilm formation. Our analysis shows oxygen level 526 is critical, affecting the whole metabolism, with only a few reaction fluxes that remain intact under hypoxic conditions 527 in respect to baseline conditions. Low oxygen not only pushes the lactate dehydrogenase towards the production of 528 lactate, but also critically affects the whole glycolytic pathway, with a reduction of sugar uptake and ATP production. 529
More NADH is consumed and less is regenerated by the GADPH enzyme, which represents one of the main bottlenecks 530 of the metabolic network. The production and accumulation of compounds such as lactate and acetate augments, 531 enhancing toxicity and acidifying the medium when exported: it is observed that the doubling time of MPN in batch 532 culture increases over time due to the decrease in media pH 28 and the accumulation of toxic waste compounds, namely 533 acetic and lactic acid. Cells growing in an acidified medium have a different membrane composition, 33 suggesting that 534 the maintenance of an optimal media pH is also critical for optimal membrane lipids composition. It is, however, still 535
unclear whether the adaptability of MPN membrane resides in its genome-coding function, if it is a chemical-physical 536 response of the lipid bilayer to pH changes or if it is a combination of these two aspects. 537
The cytosol of Mycoplasmas does not maintain a constant pH relative to the outside environment, with the risk of 538 being unable to maintain the proton gradient required for trans-membrane transport 69 and to alter the internal 539 biochemical state. Our model iEG158_mpn improves iJW145 by not only integrating the membrane, the specific lipids 540
with their pathways and carried acyl chains, but also rearranging the ATP distribution in the maintenance energy, 541 taking into account the effort made by MPN while de-acidifying the cytosol: a cytosolic pH decrease is equivalent to 542 an increase in the H3O + intracellular concentration, which might alter reactions involving H + as reactant, for instance 543 ATP hydrolysis. 70 This might be a cause of high energy maintenance costs and reduced growth rate. For this reason, a 544 study on the effects of the intracellular pH change on MPN metabolism would be of main interest. 545 A study of MPN under different environmental conditions would not only provide insights into the way it reacts to pH 546 changes, but also disclose the strategies bacteria with a reduced genome use to exploit the host's resources to 547 accomplish essential tasks, whose capabilities it has lost during the course of evolution: our analysis highlights a lack 548 of metabolic versatility, reflected by an in silico deficiency of flux variability, possibly due to an extremely reduced 549 metabolic network size. 550
Altogether, our integrated approach, demonstrates the usefulness of modeling resources for exploring the metabolic 551 capacity of mycoplasmas, and the use of these insights to rationally influence, modulate and design conditions for 552 optimized performance. 553 554
